Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:19 pm
Purchase
13GProthena Corporation plc
PRTA
Avidity Partners Management LP2,953,000
5.7%
2,953,000increase
(New Position)
View
2023-02-14
4:07 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Avidity Partners Management LP2,189,719
9.9%
69,719increase
(+3.29%)
View
2023-02-14
3:59 pm
Purchase
13GSCYNEXIS, Inc.
SCYX
Avidity Partners Management LP3,624,523
9.9%
1,385,245increase
(+61.86%)
View
2023-02-14
3:52 pm
Sale
13GESSA Pharma Inc.
EPIX
Avidity Partners Management LP1,855,400
4.2%
-1,894,600decrease
(-50.52%)
View
2023-02-14
3:49 pm
Purchase
13GAltimmune, Inc.
ALT
Avidity Partners Management LP3,990,000
8.1%
1,225,000increase
(+44.30%)
View
2023-02-14
3:47 pm
Purchase
13GSyndax Pharmaceuticals, Inc.
SNDX
Avidity Partners Management LP6,718,142
9.7%
1,474,123increase
(+28.11%)
View
2023-02-14
3:44 pm
Purchase
13GKezar Life Sciences, Inc.
KZR
Avidity Partners Management LP6,782,400
9.9%
3,554,200increase
(+110.10%)
View
2023-02-14
3:39 pm
Purchase
13GIDEAYA Biosciences, Inc.
IDYA
Avidity Partners Management LP3,824,800
7.9%
1,271,800increase
(+49.82%)
View
2023-02-14
3:38 pm
Sale
13GAlpine Immune Sciences, Inc.
ALPN
Avidity Partners Management LP1,888,887
4%
-316,800decrease
(-14.36%)
View
2023-02-14
3:31 pm
Purchase
13GKaryopharm Therapeutics Inc.
KPTI
Avidity Partners Management LP11,381,073
9.9%
29,254increase
(+0.26%)
View
2023-02-14
3:23 pm
Sale
13GGritstone bio, Inc.
GRTS
Avidity Partners Management LP2,859,971
3.3%
-4,130,223decrease
(-59.09%)
View
2023-02-14
2:58 pm
Purchase
13GAkero Therapeutics, Inc.
AKRO
Avidity Partners Management LP3,825,000
8.2%
720,000increase
(+23.19%)
View
2023-02-14
2:42 pm
Sale
13GCyteir Therapeutics, Inc.
CYT
Avidity Partners Management LP1,795,800
5.1%
-53,738decrease
(-2.91%)
View
2023-02-14
2:26 pm
Sale
13GPhaseBio Pharmaceuticals Inc
PHAS
Avidity Partners Management LP2,040,000
4.1%
-2,365,000decrease
(-53.69%)
View
2023-02-14
1:58 pm
Purchase
13GPhathom Pharmaceuticals, Inc.
PHAT
Avidity Partners Management LP1,900,000
4.6%
4,000increase
(+0.21%)
View
2023-02-14
1:38 pm
Purchase
13GArvinas, Inc.
ARVN
Avidity Partners Management LP4,950,000
9.3%
1,710,162increase
(+52.79%)
View
2023-02-14
1:10 pm
Sale
13GIVERIC bio, Inc.
ISEE
Avidity Partners Management LP838,407
0.6%
-6,116,593decrease
(-87.95%)
View
2023-02-14
12:50 pm
Sale
13GOncoSec Medical Incorporated
ONCS
Avidity Partners Management LP0
0%
-2,945,000decrease
(Position Closed)
View
2023-02-14
12:41 pm
Sale
13GAdicet Bio, Inc.
ACET
Avidity Partners Management LP0
0%
-3,034,004decrease
(Position Closed)
View
2023-02-14
12:19 pm
Sale
13GViridian Therapeutics, Inc.
VRDN
Avidity Partners Management LP0
0%
-1,278,261decrease
(Position Closed)
View
Goto 0, 1, 2, 3, Next